SCHEMBL25912261

SCHEMBL25912261

Cc1cn2c3ccccc3n(-c3c(C)cccc3C)c2n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 1/20 0.36
EPHB4 P54760 1/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
AURKA O14965 1/20 0.32
ALKBH5 Q6P6C2 1/20 0.32
FTO Q9C0B1 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
LCK P06239 1/20 0.31
GRM5 P41594 1/20 0.31
CRHR1 P34998 2/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
MAPK13 O15264 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8878415 0.73 MBD2 (0.48) ADORA3ADORA2ASMN1; SMN2MAPK1PTPN2
SCHEMBL19234007 0.71 CRHR1 (0.40) TSHREPHB4CRHR1
SCHEMBL19233704 0.70 CD44 (0.34) EPHB4ALKBH5FTO
SCHEMBL25919045 0.70 LCK (0.33) LCK
SCHEMBL19234176 0.70 EPHB4 (0.36) ADORA2AEPHB4CRHR1
SCHEMBL19229374 0.69 GABRA5 (0.37) TSHREPHB4PARP15PARP10TNKS2
SCHEMBL19233782 0.68 DPP4 (0.36) TSHREPHB4ALKBH5FTO
SCHEMBL2958307 0.66 ALKBH5 (0.53) TSHRALKBH5FTOHTT
SCHEMBL16728807 0.65 ALKBH5 (0.40) TSHRADORA3ADORA2AAURKAALKBH5
SCHEMBL13299513 0.63 ESR1 (0.56) TSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND TSHR 4682/4885ADORA3 4245/4885ADORA2A 3626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.